<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>18-URINARY-ALKALIZERS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="URINARY ALKALIZERS" code="B05-001" /></DRUG1>
<DRUG2>
<DRUG name="HYDROQUINIDINE" rxcui="27220">
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the plasma concentrations of the hydroquinidine and risk of overdose (decrease of the renal excretion of the hydroquinidine by alkalinizing of the urine)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring, EKG, and possibly testing of the concentrations of the hydroquinidine; if needed, adjustment of the dosage during the alkalinizing treatment and after it is stopped.</COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>18-URINARY-ALKALIZERS.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="URINARY ALKALIZERS" code="B05-001" /></DRUG1>
<DRUG2>
<DRUG name="QUINIDINE" rxcui="9068">
<ATC code="C01BA71" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the plasma concentrations of the quinidine and risk of overdose (decrease of the renal excretion of the quinidine by alkalinizing of the urine).</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Clinical monitoring, EKG, and possibly testing of the concentrations of quinidine; if needed, adjustment of the dosage during the alkalinizing treatment and after it is stopped.</COMMENT>
</INTERACTION>
</INTERACTIONS>
